Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.49 |
| ▸ | METAP1 | P53582 | 1/20 | 0.49 |
| ▸ | GRM5 | P41594 | 11/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22316412 | 0.89 | MAPK14 (0.44) | METAP2METAP1GRM5KDM4EALDH1A1 | |
| SCHEMBL30872068 | 0.87 | KCNH2 (0.53) | METAP2METAP1GRM5KDM4EALDH1A1 | |
| SCHEMBL24791485 | 0.87 | KCNH2 (0.53) | METAP2METAP1GRM5KDM4EALDH1A1 | |
| SCHEMBL5582180 | 0.84 | KDM4E (0.44) | METAP2METAP1KDM4EMAPK14FFAR1 | |
| SCHEMBL18411457 | 0.82 | METAP2 (0.54) | METAP2METAP1GRM5KDM4EALDH1A1 | |
| SCHEMBL24017202 | 0.81 | METAP2 (0.49) | METAP2METAP1GRM5KDM4EALDH1A1 | |
| SCHEMBL22316414 | 0.80 | KCNH2 (0.47) | METAP2METAP1GRM5KDM4EALDH1A1 | |
| SCHEMBL31663603 | 0.79 | GRM5 (0.49) | METAP2METAP1GRM5TGFBR1 | |
| SCHEMBL17540173 | 0.79 | GRM5 (0.50) | GRM5 | |
| SCHEMBL13261822 | 0.79 | METAP2 (0.50) | METAP2METAP1GRM5KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858952-B2 | Compound and color conversion film comprising same | LG CHEM, LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| US-11858952-B2 | Compound and color conversion film comprising same | LG CHEM, LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| US-20210347790-A1 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210347790-A1 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME | BLVRB, CDYL, CRY1 | METAP2 1071/4885METAP1 1136/4885GRM5 1960/4885 |
| US-11858952-B2 | Compound and color conversion film comprising same | BLVRB, CDYL, CRY1 | METAP2 1071/4885METAP1 1136/4885GRM5 1960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.